{
    "2020-07-11": [
        [
            {
                "time": "",
                "original_text": "3年8亿“输血”大股东 博雅生物蹊跷交易遭质疑",
                "features": {
                    "keywords": [
                        "博雅生物",
                        "输血",
                        "大股东",
                        "蹊跷交易",
                        "质疑"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}